BPA Call HT001421A0031-HT001425FE013
Award Date 9/8/25
Potential Completion Date 9/7/26
Potential Value $145K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
- This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
- This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The contract has a ceiling value of $30,416.18 and a period of performance ending on March 31, 2017. Genomic Health, Inc. is a for-profit organization that specializes in providing advanced genetic testing services, particularly the Oncotype DX portfolio of genomic assays, to federal...
- The Defense Health Agency awarded a $145,066 firm fixed price blanket purchase agreement call contract to Genomic Health, Inc., a division of Exact Sciences Corporation, to deliver its Oncotype Portfolio of genomic tests for earlier cancer detection and cancer treatment. The testing portfolio aims to support the Defense Health Agency's efforts to advance cancer screening and personalized treatment selection. Performance will occur in Bethesda, Maryland over one year effective September 2023....
- This contract was awarded by the Defense Health Agency to Genomic Health, Inc., a developer and manufacturer of genomic and diagnostic tests for cancer detection and treatment. The contract provides for medical laboratory testing and analysis services, including Genomic Health's Oncotype DX Breast and Oncotype DX Colon cancer tests. The contract was awarded as a Blanket Purchase Agreement (BPA) call on a Firm Fixed Price basis, with a potential value of $125,000.00. The contract does not utilize...
- This federal contract award is to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide the Oncotype DX portfolio of genomic cancer testing assays. The $149,624.97 award was issued as a Blanket Purchase Agreement (BPA) call by the Defense Health Agency, with firm fixed pricing. The contract supports the provision of Oncotype Breast Cancer Assay, Oncotype Genomic Prostate Score Assay, and Oncotype Colon Recurrence Score Assay testing services to Department of Defense and...
- This is a delivery order awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of Oncotype cancer testing services to the Defense Health Agency (DHA). The contract has a ceiling value of $124,588.79 and a period of performance from March 16, 2025, to March 15, 2026, with the testing to be performed at Nellis Air Force Base in Nevada. The contract is a firm fixed-price type and does not have a set-aside designation. Genomic Health, Inc. is a for-profit...
- This award is for a purchase order of $78,364.30 to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide breast cancer testing services to the Defense Health Agency. The contract has a firm fixed price pricing type and a completion date of September 30, 2016. Genomic Health is a for-profit organization that specializes in providing genomic cancer testing services to the federal government, including the Department of Veterans Affairs, Department of Defense, Air Force,...